https://biotechmorning.com/news/transgene-tg4050-perfect-three-year-survival Biotech Morning en 2026-09-20T14:15:14.975Z A Tiny Cancer Vaccine Trial Just Posted a Perfect Score https://biotechmorning.com/news/menarini-innovent-bofanglutide-europe-obesity-deal Biotech Morning en 2026-09-20T14:14:32.289Z Europe's Newest Obesity Drug Comes From a Place You Wouldn't Expect https://biotechmorning.com/news/novo-nordisk-drops-nordisk-rebrand Biotech Morning en 2026-09-20T14:13:43.724Z Why the World's Biggest Pharma Company Just Erased Half Its Name https://biotechmorning.com/news/zealand-pharma-zeydovio-chmp-positive-opinion-europe Biotech Morning en 2026-09-20T14:13:00.663Z Europe's First New Gut Treatment in a Decade Just Cleared a Major Hurdle https://biotechmorning.com/news/fda-expedited-ind-pilot-program-phase-1-trials Biotech Morning en 2026-09-20T14:12:15.779Z The FDA Wants to Stop Losing Its Best Drug Trials to Australia https://biotechmorning.com/news/gsk-hutchmed-hmpl-a830-adc-deal Biotech Morning en 2026-09-20T14:11:26.441Z GSK Just Spent $1.3 Billion on a Drug That Hasn't Entered a Single Patient https://biotechmorning.com/news/roche-simcere-trispecific-deal Biotech Morning en 2026-09-20T14:10:38.629Z Roche Just Paid $1.5 Billion for a Drug That Doesn't Exist Yet https://biotechmorning.com/news/skyhawk-sky-0515-huntington-pill Biotech Morning en 2026-09-20T14:09:49.833Z The Pill That Might Actually Slow Huntington's Disease https://biotechmorning.com/news/astrazeneca-camizestrant-serena4-trial-miss Biotech Morning en 2026-09-20T14:09:04.127Z AstraZeneca's Breast Cancer Pill Had One Job. It Didn't Deliver. https://biotechmorning.com/news/astrazeneca-summit-15-billion-ivonescimab-deal Biotech Morning en 2026-09-20T14:08:24.104Z The $15 Billion Handshake That Could Reshape Lung Cancer https://biotechmorning.com/news/lilly-zepbound-single-dose-vials-price-war Biotech Morning en 2026-09-19T14:14:44.868Z Lilly's $449 Bet to Win the Obesity Drug Price War https://biotechmorning.com/news/anthropic-wet-biology-lab Biotech Morning en 2026-09-19T14:13:57.222Z The AI Giant That Just Built a Biology Lab https://biotechmorning.com/news/esr1-mutation-breast-cancer-fda-approval-imlunestrant Biotech Morning en 2026-09-19T14:13:10.581Z The Breast Cancer Mutation That Finally Has a Bullseye on It https://biotechmorning.com/news/intellia-crispr-hae-one-shot-phase-3 Biotech Morning en 2026-09-19T14:12:24.431Z One Shot to Silence a Disease: Intellia's CRISPR Bet Just Paid Off https://biotechmorning.com/news/uk-250-million-life-sciences-investment Biotech Morning en 2026-09-19T14:11:37.702Z The UK Just Bet £250 Million That It Can Out-Science Everyone https://biotechmorning.com/news/cannabis-compound-doubled-semaglutide-weight-loss Biotech Morning en 2026-09-19T14:10:53.158Z The Cannabis Compound That Made Semaglutide Twice as Powerful https://biotechmorning.com/news/us-china-pharma-licensing-deal-restrictions-easing Biotech Morning en 2026-09-19T14:10:05.182Z The U.S. Almost Walled Off China's Drug Pipeline. Now It's Opening the Gate. https://biotechmorning.com/news/curium-lantheus-8-billion-radiopharmaceutical-deal-2 Biotech Morning en 2026-09-19T14:09:19.500Z Radioactive Gold: The $8 Billion Bet That Nuclear Medicine Is Biotech's Next Frontier